Volume 66, Issue 6, Pages (December 2014)

Slides:

Advertisements

Similar presentations

The PSA Era is not Over for Prostate Cancer

Advertisements

Volume 52, Issue 1, Pages (July 2007)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 44, Issue 6, Pages (December 2003)

European Urology Focus

Volume 66, Issue 6, Pages (December 2014)

Volume 58, Issue 1, Pages (July 2010)

Volume 60, Issue 2, Pages (August 2011)

Volume 199, Issue 4, Pages e235-e236 (April 2018)

European Urology Oncology

Volume 61, Issue 5, Pages (May 2012)

Volume 53, Issue 5, Pages (May 2008)

Volume 64, Issue 4, Pages (October 2013)

Volume 68, Issue 3, Pages (September 2015)

Volume 51, Issue 4, Pages (April 2007)

Volume 51, Issue 3, Pages (March 2007)

Volume 53, Issue 5, Pages (May 2008)

Volume 70, Issue 2, Pages (August 2016)

Volume 72, Issue 5, Pages (November 2017)

Prostate Cancer Epidemic in Sight?

Volume 61, Issue 4, Pages (April 2012)

Volume 64, Issue 4, Pages (October 2013)

Volume 66, Issue 3, Pages (September 2014)

Volume 63, Issue 1, Pages (January 2013)

Volume 64, Issue 4, Pages (October 2013)

The Global Risk of Bladder Cancer: Let's Just Do Something About It!

Volume 68, Issue 5, Pages (November 2015)

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Volume 61, Issue 5, Pages (May 2012)

Volume 68, Issue 1, Pages 5-7 (July 2015)

Volume 61, Issue 4, Pages (April 2012)

Volume 53, Issue 4, Pages (April 2008)

Prostate Cancer Detection: A View of the Future

Volume 67, Issue 3, Pages (March 2015)

P.M.J. Moonen, L.A.L.M. Kiemeney, J.A. Witjes European Urology

Volume 64, Issue 5, Pages (November 2013)

Volume 61, Issue 6, Pages (June 2012)

Volume 63, Issue 5, Pages (May 2013)

Volume 69, Issue 3, Pages (March 2016)

Volume 64, Issue 3, Pages (September 2013)

Counselling the Prostate Cancer Patient

Prostate Cancer Epidemic in Sight?

The PSA Era is not Over for Prostate Cancer

Volume 61, Issue 6, Pages (June 2012)

Volume 71, Issue 6, Pages (June 2017)

Volume 64, Issue 4, Pages (October 2013)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 66, Issue 6, Pages (December 2014)

Volume 61, Issue 2, Pages (February 2012)

Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review Sven van.

The Economic Costs of Overactive Bladder in Germany

Volume 53, Issue 1, Pages (January 2008)

Volume 69, Issue 6, Pages (June 2016)

Volume 70, Issue 2, Pages (August 2016)

Volume 50, Issue 5, Pages (November 2006)

Testicular Cancer Variations in Time and Space in Europe

Volume 74, Issue 4, Pages (October 2018)

The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic.

Photodynamic Therapy for Early Stage Central Type of Lung Cancer

Prognostic Impact of Comorbidity in Patients with Bladder Cancer

Bladder Cancer: Highlights from 2006

European Urology is “Your” Journal

Epidemiology of Renal Cell Carcinoma

Economic Burden of Bladder Cancer Across the European Union

Georges-Pascal Haber, Sebastien Crouzet, Inderbir S. Gill

Volume 53, Issue 2, Pages (February 2008)

Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer Sten Holmäng European Urology.

Volume 52, Issue 1, Pages (July 2007)

Volume 54, Issue 1, Pages (July 2008)

Volume 51, Issue 5, Pages (May 2007)

Presentation transcript:

Volume 66, Issue 6, Pages 1139-1147 (December 2014) Perioperative Blood Transfusion and Radical Cystectomy: Does Timing of Transfusion Affect Bladder Cancer Mortality? E. Jason Abel, Brian J. Linder, Tyler M. Bauman, Rebecca M. Bauer, R. Houston Thompson, Prabin Thapa, Octavia N. Devon, Robert F. Tarrell, Igor Frank, David F. Jarrard, Tracy M. Downs, Stephen A. Boorjian European Urology Volume 66, Issue 6, Pages 1139-1147 (December 2014) DOI: 10.1016/j.eururo.2014.08.051 Copyright © 2014 European Association of Urology Terms and Conditions

Fig. 1 (A) Recurrence-free survival (p=0.01) and (B) cancer-specific survival (p=0.004) among patients with bladder cancer treated with radical cystectomy at the University of Wisconsin, stratified by receipt and timing of perioperative blood transfusion. Intraop=intraoperative; postop=postoperative; RC=radical cystectomy. European Urology 2014 66, 1139-1147DOI: (10.1016/j.eururo.2014.08.051) Copyright © 2014 European Association of Urology Terms and Conditions

Fig. 2 (A) Recurrence-free survival (p<0.001) and (B) cancer-specific survival (p<0.001) among patients with bladder cancer treated with radical cystectomy at the Mayo Clinic, stratified by receipt and timing of perioperative blood transfusion. Intraop=intraoperative; postop=postoperative; RC=radical cystectomy. European Urology 2014 66, 1139-1147DOI: (10.1016/j.eururo.2014.08.051) Copyright © 2014 European Association of Urology Terms and Conditions